Search

Pooja Sawhney Phones & Addresses

  • 131 Surrey St, Medford, MA 02155 (781) 643-1816
  • 18 Wiseman Dr, Peabody, MA 01960 (978) 531-2683 (978) 531-4601
  • 276 Massachusetts Ave, Arlington, MA 02474 (781) 643-1816

Publications

Us Patents

Aptamers To The Human Il-12 Cytokine Family And Their Use As Autoimmune Disease Therapeutics

View page
US Patent:
20060193821, Aug 31, 2006
Filed:
Sep 22, 2005
Appl. No.:
11/234676
Inventors:
John Diener - Cambridge MA, US
David Epstein - Belmont MA, US
Alicia Ferguson - Somerville MA, US
Nobuko Hamaguchi - Framingham MA, US
Shannon Pendergrast - Cambridge MA, US
Pooja Sawhney - Arlington MA, US
Kristin Thompson - Arlington MA, US
International Classification:
A61K 48/00
C07K 14/715
C08G 63/91
US Classification:
424078370, 530350000, 525054100, 536023500, 514044000
Abstract:
The present invention provides materials and methods to treat immune disease in which cytokines are involved in pathogenesis. The materials and methods of the present invention are useful in the treatment of autoimmune diseases. The materials and methods of the present invention are directed to nucleic acid ligands capable of binding to human IL-23 and/or human IL-12 cytokines and thus modulate their biological activity and are useful as therapeutic agents in immune, auto-immune and cancer therapeutics.

Nucleic Acid Ligands Specific To Immunoglobulin E And Their Use As Atopic Disease Therapeutics

View page
US Patent:
20070009907, Jan 11, 2007
Filed:
Apr 26, 2005
Appl. No.:
11/115780
Inventors:
Paula Burmeister - Cambridge MA, US
Sharon Cload - Cambridge MA, US
John Diener - Cambridge MA, US
Anthony Keefe - Cambridge MA, US
Sara Keene - Tewksbury MA, US
Markus Kurz - Newton MA, US
Harold Marsh - Charlestown MA, US
Pooja Sawhney - Arlington MA, US
Chunhua Wang - Acton MA, US
International Classification:
C12Q 1/68
C08G 63/91
US Classification:
435006000, 525054200
Abstract:
The invention discloses aptamers capable of binding to Immunoglobulin E (“IgE”) useful as therapeutics in and diagnostics of atopic disease and/or other diseases or disorders in which IgE has been implicated. The invention further relates to materials and methods for the administration of aptamers capable of binding to IgE.

Aptamers To The Human Il-12 Cytokine Family And Their Use As Autoimmune Disease Therapeutics

View page
US Patent:
20070066550, Mar 22, 2007
Filed:
Mar 7, 2005
Appl. No.:
11/075649
Inventors:
John Diener - Cambridge MA, US
Alicia Ferguson - Somerville MA, US
Nobuko Hamaguchi - Framingham MA, US
Sara Keene - Tewksbury MA, US
Pooja Sawhney - Arlington MA, US
Kristin Thompson - Arlington MA, US
International Classification:
A61K 48/00
C07H 21/04
US Classification:
514044000, 536023500
Abstract:
The present invention provides materials and methods to treat immune disease in which cytokines are involved in pathogenesis. The materials and methods of the present invention are useful in the treatment of autoimmune diseases. The materials and methods of the present invention are directed to nucleic acid ligands capable of binding to human IL-23 and/or human IL-12 cytokines and thus modulate their biological activity and are useful as therapeutic agents in immune, auto-immune and cancer therapeutics.

Aptamers To The Human Il-12 Cytokine Family And Their Use As Autoimmune Disease Therapeutics

View page
US Patent:
20090082555, Mar 26, 2009
Filed:
Jun 9, 2008
Appl. No.:
12/157383
Inventors:
John L. Diener - Cambridge MA, US
Alicia Ferguson - Somerville MA, US
Nobuko Hamaguchi - Framingham MA, US
Sara Chesworth Keene - Tewksbury MA, US
Pooja Sawhney - Arlington MA, US
Kristin Thompson - Arlington MA, US
International Classification:
C12N 15/24
US Classification:
536 235
Abstract:
The present invention provides materials and methods to treat immune disease in which cytokines are involved in pathogenesis. The materials and methods of the present invention are useful in the treatment of autoimmune diseases. The materials and methods of the present invention are directed to nucleic acid ligands capable of binding to human IL-23 and/or human IL-12 cytokines and thus modulate their biological activity and are useful as therapeutic agents in immune, auto-immune and cancer therapeutics.
Pooja Sawhney from Medford, MA, age ~46 Get Report